Thursday, May 27, 2010

When drinking isn't that so glamorous

Breast Cancer Survival Manual, Fourth Edition: A Step-by-Step Guide for the Woman With Newly Diagnosed Breast CancerYes, women are fragile creatures. And all the more the reason that as men care for them, they should be exerting care for themselves doubly as well.

Men has all sorts of problem with women, but simply, men cannot live without women.

Ladies, do avoid that drink, if at all possible - for your own good. Merci!
-----

Oestrogen linked to benign breast disease: study


Drinking 22 to 27 drinks over the course of a week increases risk by 130 per cent.
WASHINGTON - Postmenopausal women undergoing a common oestrogen replacement regimen have more than twice the risk of developing benign breast disease than women receiving no treatment, according to a new study.

The study, first posted Tuesday in the online edition of The Journal of the National Cancer Institute, tracked some 10,739 postmenopausal women.

Some of the subjects in the study were given conjugated equine oestrogen, a commonly-prescribed form of oestrogen, while others received a placebo.

Just Get Me Through This!: The Practical Guide to Breast CancerAfter a median follow-up of seven years, the researchers found a total of 232 cases of benign proliferative breast disease -- 155 among the women who took oestrogen supplements, and about half as many, 77, in the placebo group.

The study noted that while not a harmful condition, benign proliferative breast disease often is a precursor to malignant breast cancer.

"Although the women taking conjugated equine oestrogen have not yet shown a significant increased risk of breast cancer ... they might show increased risk
later," the authors concluded.

Chicken Soup for the Breast Cancer Survivor's Soul: Stories to Inspire, Support and Heal (Chicken Soup for the Soul)"Ongoing follow-up of the study participants may help to resolve this issue," they wrote. - AFP/ra


From ChannelNewsAsia.com; source article is below:Oestrogen linked to benign breast disease: study
-----


Reblog this post [with Zemanta]

No comments:

Post a Comment